ClinicalTrialsFinder

Acquired Resistance to KRAS G12C Inhibitor Clinical Trials in Cleveland, Ohio

1 recruitingCleveland, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Colorectal, CancerColorectal CarcinomaNon-small Cell Lung Cancer+29 more
Institut de Recherches Internationales Servier554 enrolled27 locationsNCT05786924